期刊文献+

Mitofusion 2 Overexpression Decreased Proliferation of Human Embryonic Lung Fibroblasts in Acute Respiratory Distress Syndrome through Inhibiting RAS-RAF-1-ERK1/2 Pathway 被引量:6

下载PDF
导出
摘要 Acute respiratory distress syndrome(ARDS)is one of the most fatal diseases worldwide.Pulmonary fibrosis occurs early in ARDS,and its severity plays a crucial role in ARDS mortality rate.Some studies suggested that fibroproliferation is an essential mechanism in ARDS.Mitofusion2(Mfn2)overexpression plays a role in inhibiting cell proliferation.However,the role and potential mechanism of Mfn2 on the proliferation of fibroblasts is still unknown.In this study,we aimed at exploring the effect of Mfn2 on the human embryonic lung fibroblasts(HELF)and discussed its related mechanism.The HELF were treated with the Mfn2 overexpressing lentivirus(adv-Mfn2).The cell cycle was detected by flow cytometry.MTT,PCR and Western blotting were used to investigate the effect of Mfn2 on the proliferation of the HELF,collagen expression,the RAS-RAF-1-ERK1/2 pathway and the expression of cycle-related proteins(p21,p27,Rb,Raf-1,p-Raf-1,Erk1/2 and p-Erk1/2).The co-immunoprecipitation assay was used to explore the interaction between Mfn2 and Ras.The results showed that the overexpression of Mfn2 inhibited the proliferation of the HELF and induced the cell cycle arrest at the G0/G1 phase.Meanwhile,Mfn2 also inhibited the expression of collagen I,p-Erk and p-Raf-1.In addition,an interaction between Mfn2 and Ras existed in the HELF.This study suggests that the overexpression of Mfn2 can decrease the proliferation of HELF in ARDS,which was associated with the inhibition of the RAS-RAF-1-ERK1/2 pathway.The results may offer a potential therapeutic intervention for patients with ARDS.
出处 《Current Medical Science》 SCIE CAS 2020年第6期1092-1098,共7页 当代医学科学(英文)
基金 This project was supported by Wuhan Medical Science Foundation of China(No.WX17B07,No.WX19A09,and No.WJ2019H324).
  • 相关文献

参考文献1

二级参考文献26

  • 1Braun-Dullaeus RC,Mann M J,Dzau VJ. Cell cycle progression:new therapeutic target for vascular proliferative disease[J].Circulation,1998,(01):82-89.
  • 2Roger VL,Go AS,Lloyd-Jones DM. Heart disease and stroke statistics--2011 update:a report from the American Heart Association[J].Circulation,2011,(04):e18-e209.doi:10.1161/CIR.0b013e3182009701.
  • 3Ross R. Atherosclerosis is an inflammatory disease[J].American Heart Journal,1999,(5 Pt 2):S419-S420.doi:10.1016/S0002-8703(99)70266-8.
  • 4Dzau VJ,Braun-Dullaeus RC,Sedding DG. Vascular proliferation and atherosclerosis:new perspectives and therapeutic strategies[J].Nature Medicine,2002,(11):1249-1256.
  • 5Andrés V,Castro C. Antiproliferative strategies for the treatment of vascular proliferative disease[J].Current Vascular Pharmacology,2003,(01):85-98.
  • 6Charron T,Nili N,Strauss BH. The cell cycle:a critical therapeutic target to prevent vascular proliferative disease[J].Canadian Journal of Cardiology,2006,(Suppl B):41B-55B.
  • 7Brasier AR,Recinos A 3rd,Eledrisi MS. Vascular inflammation and the renin-angiotensin system[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2002,(08):1257-1266.
  • 8Vaughan DE. Angiotensin and vascular fibrinolytic balance[J].American Journal of Hypertension,2002,(1 Pt 2):3S-8S.doi:10.1016/S0895-7061(01)02273-7.
  • 9Chen KH,Guo X,Ma D. Dysregulation of HSG triggers vascular proliferative disorders[J].Nature Cell Biology,2004,(09):872-883.doi:10.1038/ncb1161.
  • 10Eguchi S,Matsumoto T,Motley ED. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin Ⅱ in cultured rat vascular smooth muscle cells.Possible requirement of Gq-mediatedp21rasactivationcoupled toaCa2+/ calmodulin-sensitive tyrosine kinase[J].Journal of Biological Chemistry,1996,(24):14169-14175.

共引文献3

同被引文献17

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部